Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Elissa Abrams and Marcus Shaker.
Elissa Abrams
Connection Strength
4.494
Marcus Shaker
  1. The Revenge of Unintended Consequences of Anaphylaxis-Risk Overdiagnosis: How Far We Have Come and How Far We Have to Go. J Allergy Clin Immunol Pract. 2021 11; 9(11):3911-3917.
    View in: PubMed
    Score: 0.951
  2. Ten tips for improving your clinical practice during the COVID-19 pandemic. Curr Opin Pediatr. 2021 Apr 01; 33(2):260-267.
    View in: PubMed
    Score: 0.938
  3. COVID-19 vaccines: addressing hesitancy in young people with allergies. Lancet Respir Med. 2021 10; 9(10):1090-1092.
    View in: PubMed
    Score: 0.241
  4. Reply to "How important is the second dose of the COVID-19 mRNA vaccine?" J Allergy Clin Immunol Pract. 2021 06; 9(6):2537-2539.
    View in: PubMed
    Score: 0.237
  5. Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada. Ann Allergy Asthma Immunol. 2021 10; 127(4):446-450.e1.
    View in: PubMed
    Score: 0.236
  6. The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis. J Allergy Clin Immunol Pract. 2021 07; 9(7):2556-2561.
    View in: PubMed
    Score: 0.235
  7. School Attendance, Asthma Risk, and COVID-19 in Children. J Allergy Clin Immunol Pract. 2021 06; 9(6):2145-2150.
    View in: PubMed
    Score: 0.234
  8. A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies. J Allergy Clin Immunol Pract. 2021 07; 9(7):2658-2668.e3.
    View in: PubMed
    Score: 0.233
  9. The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World. J Allergy Clin Immunol Pract. 2021 04; 9(4):1438-1441.
    View in: PubMed
    Score: 0.232
  10. What the COVID-19 Pandemic Can Teach Us About Resource Stewardship and Quality in Health Care. J Allergy Clin Immunol Pract. 2021 02; 9(2):608-612.
    View in: PubMed
    Score: 0.229
  11. The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19. J Allergy Clin Immunol Pract. 2020 09; 8(8):2474-2480.e1.
    View in: PubMed
    Score: 0.223
  12. Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2310-2321.e4.
    View in: PubMed
    Score: 0.220
  13. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract. 2021 10; 9(10):3546-3567.
    View in: PubMed
    Score: 0.059
  14. Media Influence on Anxiety, Health Utility, and Health Beliefs Early in the SARS-CoV-2 Pandemic-a Survey Study. J Gen Intern Med. 2021 05; 36(5):1327-1337.
    View in: PubMed
    Score: 0.058
  15. Novel Approaches to Food Allergy Management During COVID-19 Inspire Long-Term Change. J Allergy Clin Immunol Pract. 2020 10; 8(9):2851-2857.
    View in: PubMed
    Score: 0.056
  16. Managing Food Allergy in Schools During the COVID-19 Pandemic. J Allergy Clin Immunol Pract. 2020 10; 8(9):2845-2850.
    View in: PubMed
    Score: 0.056
  17. A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2125-2134.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.